Acme United Corporation

$45.38 ▲ 2.46%
2026-06-19 04:57:13

Explore Acme United Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$172.91 M
Current Price
$45.38
52W High / Low
$47.31 / $35.5
Stock P/E
19.56
Book Value
$30.63
Dividend Yield
0.01%
ROCE
ROE
0.08%
Face Value
EPS
$2.32
Exp Qtr EPS
Sector
Consumer Defensive

Pros

No pros available.

Cons

No cons available.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. The Procter & Gamble Company $152.75 21.17 $351.71 B 2.85% 22.93% 31.23% $167.25 / $137.62 $22.21
2. Colgate-Palmolive Company $95.03 36.51 $76.19 B 2.27% 44.67% 475.13% $99.33 / $74.55 $0.07
3. Kimberly-Clark Corporation $114.74 18.11 $38.38 B 4.46% 23.57% 143.64% $137.46 / $92.42 $4.53
4. Kenvue Inc. $19.78 23.5 $38.12 B 4.2% 12.85% 15.18% $22.87 / $14.02 $5.62
5. The Estée Lauder Companies Inc. $84.44 $31.11 B 1.65% 7.89% -6.29% $121.64 / $66.22 $10.74
6. Church & Dwight Co., Inc. $98.95 32.13 $23.55 B 1.26% 14.53% 17.45% $106.04 / $81.33 $16.92
7. The Clorox Company $97.41 15.76 $11.92 B 5.1% 32.32% 453.68% $132.03 / $84.7 $2.62

Quarterly Results

Figures shown in M / B

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Sales52.3 M47.52 M49.06 M54 M45.96 M
Operating Profit1.75 M2.9 M3.01 M6.39 M2.43 M
Net Profit0.98 M1.88 M1.9 M4.75 M1.65 M
EPS in Rs0.260.490.51.260.44

Profit & Loss

Figures shown in M / B

2025202420232022
Sales196.54 M194.49 M191.5 M193.96 M
Operating Profit14.72 M14.14 M13.19 M6.27 M
Net Profit10.18 M10.02 M17.79 M3.03 M
EPS in Rs2.692.714.980.86

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets171 M162.17 M149.24 M164.38 M
Total Liabilities53.39 M55.19 M51.34 M85.35 M
Equity117.61 M106.98 M97.9 M79.03 M
Current Assets96.2 M95.46 M92.02 M105.6 M
Current Liabilities22.87 M22.87 M26.01 M22.13 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF18.23 M11.98 M28.9 M2.89 M
Investing CF-12.3 M-12.94 M7.43 M-14.23 M
Financing CF-8.88 M2 M-38.44 M14.28 M
Free CF7.58 M4.83 M23.92 M-1.71 M
Capex-10.65 M-7.15 M-4.98 M-4.6 M

5Y Margin & Growth History

Last 5 years of annual financial statement data.

2024202320222021
Revenue Growth %1.56%-1.27%
Earnings Growth %-43.67%486.31%
Profit Margin %5.15%9.29%1.56%
Operating Margin %7.27%6.89%3.23%
Gross Margin %39.26%37.71%32.77%
EBITDA Margin %10.44%16.13%5.48%

Dividend & Split History

Latest dividend payments and stock split events.

Dividend History

Ex DateDividend
2026-03-25$0.16
2026-01-06$0.16
2025-10-03$0.16
2025-07-03$0.16
2025-03-26$0.15
2025-01-06$0.15
2024-10-04$0.15
2024-07-02$0.15
2024-03-27$0.15
2024-01-04$0.15
2023-10-03$0.14
2023-06-30$0.14
2023-03-30$0.14
2023-01-05$0.14
2022-09-30$0.14
2022-06-30$0.14
2022-03-31$0.13
2022-01-06$0.13
2021-09-30$0.13
2021-07-01$0.13

Stock Splits

DateSplit
1983-07-261:1.33333
1980-08-041:1.25

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
American Century ETF Trust-Avantis U.S. Small Cap Value ETF Mutual Fund 0.04 M $1.7 M 0.01% 2026-05-31
iShares Trust-iShares Russell 2000 ETF Mutual Fund 0.07 M $3.04 M 0.02% 2026-04-30
Capital Management Corporation Institutional 0.5 M $22.73 M 0.13% 2026-03-31
Mink Brook Asset Management LLC Institutional 0.38 M $17.27 M 0.1% 2026-03-31
North Star Investment Management Corp Institutional 0.25 M $11.46 M 0.07% 2026-03-31
Dimensional Fund Advisors LP Institutional 0.17 M $7.79 M 0.04% 2026-03-31
Blackrock Inc. Institutional 0.17 M $7.52 M 0.04% 2026-03-31
Royce & Associates LP Institutional 0.15 M $6.64 M 0.04% 2026-03-31
Vanguard Capital Management LLC Institutional 0.14 M $6.4 M 0.04% 2026-03-31
Renaissance Technologies, LLC Institutional 0.12 M $5.29 M 0.03% 2026-03-31
Bard Associates Inc. Institutional 0.11 M $4.96 M 0.03% 2026-03-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund Mutual Fund 0.1 M $4.57 M 0.03% 2026-03-31
Geode Capital Management, LLC Institutional 0.08 M $3.49 M 0.02% 2026-03-31
ROYCE MICRO-CAP TRUST, INC.-Royce Micro-Cap Trust Inc Mutual Fund 0.07 M $3 M 0.02% 2026-03-31
ROYCE FUND-Royce Micro-Cap Fund Mutual Fund 0.06 M $2.77 M 0.02% 2026-03-31

Frequently Asked Questions — Acme United Corporation

Will Acme United Corporation stock hit $54 in 2026?

Acme United Corporation (ACU) is currently trading at $45.38, with a 52-week range of $35.5 to $47.31. Reaching the $54 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Wall Street analysts currently have a consensus price target of $53.0 for Acme United Corporation, with a Hold rating, and the most bullish analysts see the stock reaching as high as $53.0. Whether Acme United Corporation can reach $54 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Consumer Defensive space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Short-term price predictions carry significant uncertainty — stock prices can be influenced by factors ranging from quarterly earnings surprises to global macroeconomic events. Use the ACU Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Is Acme United Corporation stock worth buying at $45.38?

Whether Acme United Corporation (ACU) is worth buying at $45.38 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Acme United Corporation trades at a Price-to-Earnings (P/E) ratio of 19.6x, which can be compared against other Consumer Defensive companies to assess whether the stock is expensive or attractively priced relative to its peers.

Profitability & efficiency: Its Return on Equity (ROE) stands at 0.1%.

Financial health: The Debt-to-Equity ratio of 42.32 indicates a higher degree of financial leverage — investors should monitor debt servicing capacity.

Analyst view: The Wall Street consensus recommendation for ACU is currently Hold, with a mean price target of $53.0 based on 1 analyst ratings. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

What is the analyst price target for Acme United Corporation (ACU) in 2026?

As of 2026, Wall Street analysts have set a consensus (mean) price target of $53.0 for Acme United Corporation (ACU), aggregated from 1 analyst ratings. The overall analyst recommendation is Hold.

The price target range spans from $53.0 on the bearish end to $53.0 on the most optimistic projection, with a median target of $53.0. This wide range reflects differing views on Acme United Corporation's growth prospects, competitive positioning, and macroeconomic sensitivity.

It is important to note that analyst price targets are forward-looking estimates based on financial models, earnings projections, and sector assumptions — they are not guarantees. Targets are regularly revised following quarterly earnings results, management guidance updates, or shifts in the broader economic outlook. Stocks can trade significantly above or below analyst targets depending on market conditions. View the full analyst breakdown and track target revisions on the ACU analysis page on StockSifting.

Is Acme United Corporation overvalued at a P/E ratio of 19.6x?

Acme United Corporation (ACU) currently has a Price-to-Earnings (P/E) ratio of 19.6x, meaning investors are paying $19.6 for every $1 of the company's trailing twelve-month earnings. Whether this makes the stock overvalued depends on several contextual factors:

Sector context: The Consumer Defensive sector tends to command higher valuation multiples when growth expectations are elevated. A 19.6x P/E falls within a moderate range, reflecting reasonable market confidence in Acme United Corporation's earnings outlook.

Growth-adjusted valuation: A P/E ratio in isolation can be misleading. Fast-growing companies often deserve higher P/E multiples because their future earnings are expected to rise significantly. A more complete picture comes from looking at the PEG ratio (P/E divided by earnings growth rate) — a PEG below 1 is often considered undervalued, while above 2 may signal overvaluation.

Additional metrics to review: P/E is just one lens. Compare it alongside the Price-to-Book (P/B) ratio, EV/EBITDA, Price-to-Sales, and free cash flow yield for a more complete valuation picture. View all of ACU's valuation ratios on StockSifting's ratios section. Valuation is subjective and context-dependent — this is not investment advice.

What will Acme United Corporation stock be worth in 2029?

Projecting Acme United Corporation (ACU)'s stock price 3 years into the future — to 2029 — requires making assumptions about the company's earnings growth, valuation multiple, and broader market conditions. No projection is guaranteed, but historical growth rates offer a reasonable starting point.

In reality, stock prices rarely follow a straight-line trajectory. Short-term volatility, earnings misses, sector rotations, interest rate changes, and macroeconomic events can all cause significant deviations from any modeled path. Investors with a 3-year horizon should focus on the fundamental business trajectory — revenue growth, expanding margins, and free cash flow generation — rather than short-term price fluctuations.

You can model different scenarios — conservative, base, and bull case — using the ACU Return Calculator on StockSifting. Enter any investment amount and CAGR assumption to see projected outcomes over your chosen time horizon. All projections are mathematical estimates only and do not constitute financial advice.